Navigation Links
High Unemployment Rates in North Carolina Will Continue to Dictate the Decrease of Commercial Health Plan Enrollment and the Increase of Medicaid Enrollment
Date:10/28/2010

NASHVILLE, Tenn., Oct. 28 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that high unemployment rates in North Carolina will continue to dictate decreasing commercial health plan enrollment rates and rising Medicaid enrollment rates. However, according to the Carolinas Health Plan Analysis, there is less state funding available to deal with increasing Medicaid enrollment.

The report finds that in order to compensate for this, the state is putting cost-saving measures in place. North Carolina has moved to decrease its drug spending by utilizing a preferred drug list, which will confine drug choices to clinically effective generics and lower-cost alternatives whenever possible. Branded drugs will only be available to recipients on a prior-approval basis. In addition, state legislators have agreed to allow the North Carolina Department of Health and Human Services to enter a multistate purchasing pool to leverage drug rebates and discounts from pharmaceutical companies.

"Compared to other states, North Carolina is late to the table with a preferred drug list," states Jan Shuxteau, market analyst with HealthLeaders-InterStudy. "Pharmaceutical companies will face barriers in the state with prior authorizations and an emphasis on generics. In addition, expect the Department of Health and Human Services to negotiate directly with pharma companies and contract with a pharmacy benefit manager for negotiated discounts and rebates."

Other topics highlighted in the recent Carolinas Health Plan Analysis include:

  • How South Carolina is responding to its increasing Medicaid enrollment.
  • Blue Cross and Blue Shield of North Carolina, the largest plan in the state, and its plan to cut administrative costs by 20 percent.
  • The move by Humana to add the Carolinas HealthCare System to its provider network.

  • Why Pharmaceutical Company Managed Markets Teams Need Health Plan AnalysisHealth Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly, Health Plan Analysis provides a detailed look at plan design and financials, as well as information about mergers, legislation and other influencers driving healthcare in a particular region.

    About HealthLeaders-InterStudy HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

    About Decision Resources, Inc. Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com .

    All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact: Erin O'Leary

    Elizabeth Marshall HealthLeaders-InterStudy

    Decision Resources, Inc. 781-993-2641

    781-993-2563 eoleary@dresources.com

    emarshall@dresources.com
    '/>"/>

    SOURCE HealthLeaders-InterStudy
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Unemployment, Health Care Spending Affect Mortality
    2. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
    3. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
    4. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
    5. GlaxoSmithKline Accelerates Review of Exelixis XL880
    6. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
    7. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
    8. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
    9. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
    10. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
    11. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... 24, 2016 According to a ... (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, ... Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & ... studies the market for the forecast period of 2016 ... 2.81 Billion by 2021 from USD 1.65 Billion in ...
    (Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
    (Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
    Breaking Medicine Technology:
    (Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
    (Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
    (Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
    (Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
    (Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
    Breaking Medicine News(10 mins):